Literature DB >> 8876392

Long-term results of surgery for superior oblique palsy.

T Maruo1, H Iwashige, N Kubota, T Sakaue, T Ishida, M Honda, T Hayashi, C Usui.   

Abstract

The results one month after surgery in 159 cases of superior oblique palsy were compared according to the method of surgery with the results 4 years or longer after surgery. There were 141 cases of congenital palsy and 18 cases of acquired palsy, for a total of 159 cases. Our study showed that surgery on the oblique muscle provided long-lasting effects, while recession of the superior rectus muscle or recession of the contralateral inferior rectus muscle could cause late overcorrection. When performing surgery on the rectus muscle, careful attention must be paid to suturing the muscle.

Entities:  

Mesh:

Year:  1996        PMID: 8876392

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  4 in total

1.  Predictive factors for corrective effect of inferior rectus recession for congenital superior oblique palsy.

Authors:  Manabu Miyata; Kiyo Shibata; Ichiro Hamasaki; Masayuki Hata; Yuki Muraoka; Munemitsu Yoshikawa; Satoshi Hasebe; Hiroshi Ohtsuki
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-11-07       Impact factor: 3.117

2.  Does inferior oblique recession cause overcorrections in laterally incomitant small hypertropias due to superior oblique palsy?

Authors:  Karen Hendler; Stacy L Pineles; Joseph L Demer; Arthur L Rosenbaum; Guillermo Velez; Federico G Velez
Journal:  Br J Ophthalmol       Date:  2012-11-10       Impact factor: 4.638

3.  Surgical Outcomes of Inferior Oblique Myectomy in Unilateral Congenital Superior Oblique Palsy with or without Trochlear Nerve.

Authors:  Ji Eun Lee; Hee Kyung Yang; Jeong-Min Hwang
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

4.  Evaluation of Surgical Strategy Based on the Intraoperative Superior Oblique Tendon Traction Test.

Authors:  Miwa Komori; Hiroko Suzuki; Akiko Hikoya; Mayu Sawada; Yoshihiro Hotta; Miho Sato
Journal:  PLoS One       Date:  2016-12-16       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.